These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7378886)

  • 21. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis.
    Pshezhetsky AV; Richard C; Michaud L; Igdoura S; Wang S; Elsliger MA; Qu J; Leclerc D; Gravel R; Dallaire L; Potier M
    Nat Genet; 1997 Mar; 15(3):316-20. PubMed ID: 9054950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sialidosis type 2 (acid neuraminidase deficiency): clinical and biochemical features of a further case.
    Winter RM; Swallow DM; Baraitser M; Purkiss P
    Clin Genet; 1980 Sep; 18(3):203-10. PubMed ID: 6777097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sialidoses.
    Franceschetti S; Canafoglia L
    Epileptic Disord; 2016 Sep; 18(S2):89-93. PubMed ID: 27621198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fundus autofluorescence and optical coherence tomography of a macular cherry-red spot in a case report of sialidosis.
    Zou W; Wang X; Tian G
    BMC Ophthalmol; 2016 Mar; 16():30. PubMed ID: 27004518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodality evoked potentials and EEG in a case of cherry red spot-myoclonus syndrome and alpha-neuraminidase deficiency (sialidosis type 1).
    Louboutin JP; Nogues B; Caillaud C; Elie B
    Eur Neurol; 1995; 35(3):175-7. PubMed ID: 7628501
    [No Abstract]   [Full Text] [Related]  

  • 26. Optical coherence tomography findings in a patient with type 1 sialidosis.
    Kersten HM; Roxburgh RH; Danesh-Meyer HV; Hutchinson DO
    J Clin Neurosci; 2016 Sep; 31():199-201. PubMed ID: 27052257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macular cherry-red spots and myoclonus with dementia: coexistent neuraminidase and beta-galactosidase deficiencies.
    Wenger DA; Tarby TJ; Wharton C
    Biochem Biophys Res Commun; 1978 May; 82(2):589-95. PubMed ID: 96839
    [No Abstract]   [Full Text] [Related]  

  • 28. Sialidosis: a review of human neuraminidase deficiency.
    Lowden JA; O'Brien JS
    Am J Hum Genet; 1979 Jan; 31(1):1-18. PubMed ID: 107795
    [No Abstract]   [Full Text] [Related]  

  • 29. Alternating dissociated nystagmus with palatal myoclonus--a case report.
    Roh JK; La JH; Yoon BW; Lee IK; Lee SB; Myung HJ
    J Korean Med Sci; 1991 Jun; 6(2):191-5. PubMed ID: 1751024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological studies of myoclonus in sialidosis type 2.
    Tobimatsu S; Fukui R; Shibasaki H; Kato M; Kuroiwa Y
    Electroencephalogr Clin Neurophysiol; 1985 Jan; 60(1):16-22. PubMed ID: 2578348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral neuropathy in the cherry-red spot-myoclonus syndrome (sialidosis type I).
    Steinman L; Tharp BR; Dorfman LJ; Forno LS; Sogg RL; Kelts KA; O'Brien JS
    Ann Neurol; 1980 May; 7(5):450-6. PubMed ID: 6249183
    [No Abstract]   [Full Text] [Related]  

  • 32. Sialidosis type I: ophthalmological findings.
    Sobral I; Cachulo Mda L; Figueira J; Silva R
    BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25323282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biochemical diagnosis of sialidosis in a child with a "cherry spot" in the fundus oculi as the main clinical symptom of the disease].
    Tsvetkova IV; Petushkova NA; Rozenfel'd EL; Barashnev IuI; Semiachkina AN
    Vopr Med Khim; 1984; 30(5):81-3. PubMed ID: 6241373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compound heterozygous mutations in the neuraminidase 1 gene in type 1 sialidosis: A case report and review of literature.
    Cao LX; Liu Y; Song ZJ; Zhang BR; Long WY; Zhao GH
    World J Clin Cases; 2021 Jan; 9(3):623-631. PubMed ID: 33553400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular pathology of NEU1 gene in sialidosis.
    Seyrantepe V; Poupetova H; Froissart R; Zabot MT; Maire I; Pshezhetsky AV
    Hum Mutat; 2003 Nov; 22(5):343-52. PubMed ID: 14517945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan.
    Gascon G; Wallenberg B; Daif AK; Ozand P
    Ann Neurol; 1988 Sep; 24(3):453-5. PubMed ID: 3265864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated sialidase activity in transformed lymphocytes by Epstein-Barr (EB) virus of sialidosis type I (cherry-red spot-myoclonus syndrome).
    Yamamoto M; Yamauchi T; Yamamoto K; Kobayashi T
    J Neurol Sci; 1995 Jul; 131(1):105-7. PubMed ID: 7561940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical study of sialidosis type I in a Russian family.
    Tsvetkova IV; Petushkova NA; Zolotuchina TV; Kucharenko VI; Rosenfeld EL
    J Inherit Metab Dis; 1987; 10(1):18-23. PubMed ID: 3106711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cherry red spot in sialidosis (mucolipidosis type I).
    Heroman JW; Rychwalski P; Barr CC
    Arch Ophthalmol; 2008 Feb; 126(2):270-1. PubMed ID: 18268224
    [No Abstract]   [Full Text] [Related]  

  • 40. A longitudinal study of Taiwanese sialidosis type 1: an insight into the concept of cherry-red spot myoclonus syndrome.
    Lai SC; Chen RS; Wu Chou YH; Chang HC; Kao LY; Huang YZ; Weng YH; Chen JK; Hwu WL; Lu CS
    Eur J Neurol; 2009 Aug; 16(8):912-9. PubMed ID: 19473359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.